RecruitingNCT03826264

Transpacific TAVR Registry

a Multinational Multicenter Prospective Transpacific TAVR Registry

Sponsor

Duk-Woo Park, MD

Enrollment

10,000 participants

Start Date

Jun 15, 2019

Study Type

OBSERVATIONAL

Conditions

Heart Valve Diseases Aortic Valve Insufficiency

Summary

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Eligibility

Min Age: 19 Years

Inclusion Criteria2

All patients undergoing TAVR
Informed consent

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETAVR

transcatheter aortic valve replacement (TAVR)

Locations(7)

Stanford University

Stanford, California, United States

Northwestern Memorial Hospital

Chicago, Illinois, United States

Second Affiliated Hospital of Zhejiang University

Hangzhou, China

Bucheon Sejong Hospital

Bucheon-si, South Korea

Chungnam National University Hospital

Daejeon, South Korea

Asan Medical Center

Seoul, South Korea

Seoul National University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03826264

Related Trials

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

NCT0314215292 locations

London Valvular Heart Disease and Reduced Ejection Fraction Detection in a Multi-ethnic Community Using Cardiac Ultrasound

NCT052085671 location

GLS in Difficult CPB Weaning

NCT073909032 locations

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

NCT0517297335 locations

The TRICURE EFS Study

NCT065069428 locations